Detalhe da pesquisa
1.
Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48-96â weeks of RETROBIC Study.
J Antimicrob Chemother
; 79(3): 595-607, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38267266